Literature DB >> 12921220

A review of olanzapine-associated toxicity and fatality in overdose.

Pierre Chue1, Peter Singer.   

Abstract

OBJECTIVE: Given the increasing use of atypical antipsychotics in psychiatric populations and the very limited data concerning the safety of such drugs, we examined the available data on olanzapine in untreated overdose situations.
METHODS: Available toxicity data concerning olanzapine were obtained from the Offices of the Medical Examiners of Canada, the Canadian Adverse Drug Reaction Monitoring Program and a review of the literature.
RESULTS: Despite the complexities and limitations of postmortem data analysis, 29 deaths were identified where an overdose of olanzapine was either the principal cause of toxicity or a significant contributor in combined toxicity.
CONCLUSIONS: Olanzapine is associated with toxicity in certain overdose situations, but evidence of any relation is limited and likely influenced by the higher rates of cardiovascular disease and sudden death in subjects with schizophrenia. RECOMMENDATIONS: Similar toxicity data reviews should be conducted for all commonly prescribed psychotropics. Early signal detection and effective notification processes are crucial in the event that serious adverse effects do occur.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12921220      PMCID: PMC165790     

Source DB:  PubMed          Journal:  J Psychiatry Neurosci        ISSN: 1180-4882            Impact factor:   6.186


  34 in total

1.  1998 annual report of the American Association of Poison Control Centers Toxic Exposure Surveillance System.

Authors:  T L Litovitz; W Klein-Schwartz; E M Caravati; J Youniss; B Crouch; S Lee
Journal:  Am J Emerg Med       Date:  1999-09       Impact factor: 2.469

2.  Olanzapine overdose in a 1-year-old male.

Authors:  M M Bonin; K K Burkhart
Journal:  Pediatr Emerg Care       Date:  1999-08       Impact factor: 1.454

Review 3.  New onset diabetes and atypical antipsychotics.

Authors:  K A Liebzeit; J S Markowitz; C F Caley
Journal:  Eur Neuropsychopharmacol       Date:  2001-02       Impact factor: 4.600

4.  Olanzapine overdose cause of acute extrapyramidal symptoms.

Authors:  R A Chambers; A Caracansi; G Weiss
Journal:  Am J Psychiatry       Date:  1998-11       Impact factor: 18.112

5.  Olanzapine overdose.

Authors:  J Fogel; J E Díaz
Journal:  Ann Emerg Med       Date:  1998-08       Impact factor: 5.721

6.  Olanzapine increases weight and serum triglyceride levels.

Authors:  D N Osser; D M Najarian; R L Dufresne
Journal:  J Clin Psychiatry       Date:  1999-11       Impact factor: 4.384

7.  Different fatal toxicity of neuroleptics identified by autopsy.

Authors:  D Schreinzer; R Frey; T Stimpfl; W Vycudilik; A Berzlanovich; S Kasper
Journal:  Eur Neuropsychopharmacol       Date:  2001-04       Impact factor: 4.600

8.  Olanzapine overdose mimicking opioid intoxication.

Authors:  G F O'Malley; S Seifert; K Heard; F Daly; R C Dart
Journal:  Ann Emerg Med       Date:  1999-08       Impact factor: 5.721

9.  Olanzapine concentrations in clinical serum and postmortem blood specimens--when does therapeutic become toxic?

Authors:  M D Robertson; M M McMullin
Journal:  J Forensic Sci       Date:  2000-03       Impact factor: 1.832

Review 10.  Schizophrenia and sudden death: a medical examiner case study.

Authors:  D Chute; C Grove; B Rajasekhara; J E Smialek
Journal:  Am J Forensic Med Pathol       Date:  1999-06       Impact factor: 0.921

View more
  11 in total

Review 1.  Liver and peripheral blood concentration ratio (L/P) as a marker of postmortem drug redistribution: a literature review.

Authors:  Iain M McIntyre
Journal:  Forensic Sci Med Pathol       Date:  2013-11-07       Impact factor: 2.007

2.  A case of sinus pause induced by swallowing in the setting of olanzapine and guanfacine overdose.

Authors:  Andrew R Kolarich; Matthew Mubarak; Shannon Wells; Christopher T Campbell; Ravi S Samraj
Journal:  J Intensive Care Soc       Date:  2018-07-05

Review 3.  Does olanzapine warrant clinical pharmacokinetic monitoring in schizophrenia?

Authors:  Erin Schwenger; Jane Dumontet; Mary H H Ensom
Journal:  Clin Pharmacokinet       Date:  2011-07       Impact factor: 6.447

Review 4.  Olanzapine poisoning in patients treated at the National Poison Control Centre in Belgrade, Serbia in 2017 and 2018: a brief review of serum concentrations and clinical symptoms.

Authors:  Snežana Đorđević; Nataša Perković Vukčević; Marko Antunović; Vesna Kilibarda; Gordana Vuković Ercegović; Jasmina Jović Stošić; Slavica Vučinić
Journal:  Arh Hig Rada Toksikol       Date:  2022-07-07       Impact factor: 2.078

5.  Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients.

Authors:  Ann E Maloney; Linmarie Sikich
Journal:  Neuropsychiatr Dis Treat       Date:  2010-11-10       Impact factor: 2.570

6.  Pontine haemorrhage mimicked by an olanzapine overdose.

Authors:  C Broyd; A McGuinness
Journal:  Emerg Med J       Date:  2006-04       Impact factor: 2.740

7.  Olanzapine overdose presenting with acute muscle toxicity.

Authors:  Niraj Keyal; Gentle Sunder Shrestha; Saurabh Pradhan; Ramesh Maharjan; Subhash Prasad Acharya; Moda Nath Marhatta
Journal:  Int J Crit Illn Inj Sci       Date:  2017 Jan-Mar

8.  Patient Survival After Acute Voluntary Poisoning With a Huge Dose of Oxcarbazepine and Olanzapine.

Authors:  Vasiliki Kalogera; Dimitrios Galopoulos; Gerasimos Eleftheriotis; Evangelia Meimeti; Ioannis Malios; Georgios Marathonitis; Chariclia Loupa
Journal:  Med Arch       Date:  2018-10

9.  Olanzapinium dipicrate.

Authors:  C N Kavitha; Jerry P Jasinski; Amanda C Keeley; H S Yathirajan; A S Dayananda
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2013-01-12

10.  Bilateral Basal Ganglion Hemorrhage after Severe Olanzapine Intoxication.

Authors:  Kerstin Schweyer; Bastian Fatke; Kornelia Kreiser; Christian Rabe; Christian Seifert; Benno Ikenberg
Journal:  Case Rep Psychiatry       Date:  2020-08-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.